Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics

BACKGROUND: Benralizumab is highly effective in many, but not all, patients with severe asthma. Baseline characteristics alone are insufficient to predict an individual's probability of long-term benralizumab response. The objectives of the present study were to: 1) study whether parameters at...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroes, Johannes A., de Jong, Kim, Hashimoto, Simone, Zielhuis, Sander W., van Roon, Eric N., Sont, Jacob K., ten Brinke, Anneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086738/
https://www.ncbi.nlm.nih.gov/pubmed/37057095
http://dx.doi.org/10.1183/23120541.00559-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086738/
https://www.ncbi.nlm.nih.gov/pubmed/37057095
http://dx.doi.org/10.1183/23120541.00559-2022

Ejemplares similares